- •Low- and high-income countries found the highest mortality and incidence separately.
- •Positive relation for GDP, HDI and alcohol drinking with prostate cancer incidence.
- •An increasing incidence but decreasing mortality of prostate cancer.
- •The incidence increase was also found in the younger population aged <50 years.
Materials and Methods
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Clinical Genitourinary Cancer
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin. 2021; 71: 209-249
- Global Cancer Observatory: Cancer Today.International Agency for Research on Cancer, Lyon, France2020 (Available at:)Accessed: July 10, 2021)
American Cancer Society. Prostate cancer risk factors. Available at: https://www.cancer.org/cancer/prostate-cancer/causes-risks-prevention/risk-factors.html. Accessed, July 20, 2021. 2020.
- Risk factors for prostate cancer.Nat Clin Pract Urol. 2009; 6: 87-95
- American Cancer Society guideline for the early detection of prostate cancer: update 2010.CA Cancer J Clin. 2010; 60: 70-98
- EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer—2020 Update. Part 1: screening, diagnosis, and local treatment with curative intent.Eur Urol. 2021; 79: 243-262
- Global incidence and mortality for prostate cancer: analysis of temporal patterns and trends in 36 countries.Eur Urol. 2016; 70: 862-874
- Recent global patterns in prostate cancer incidence and mortality rates.Eur Urol. 2020; 77: 38-52
United Nations. Human development classification, 2018 statistical update: Available at: http://hdr.undp.org/sites/default/files/2018_human_development_statistical_update.pdf. 2018: Accesses, July 30, 2020.
- Bray F CM Mery L Piñeros M Znaor A Zanetti R Ferlay J Cancer Incidence in Five Continents, Vol. XI (electronic version). International Agency for Research on Cancer, Lyon2017
Danckert BFJ, Engholm G, Hansen HL, et al. NORDCAN: cancer incidence, mortality, prevalence and survival in the Nordic Countries, version 8.2 (26.03.2019): Available at: https://www-dep.iarc.fr/NORDCAN/english/frame.asp. 2019: Accessed, May 10, 2020.
- NORDCAN–a Nordic tool for cancer information, planning, quality control and research.Acta Oncol. 2010; 49: 725-736
U.S. Department of Health and Human Services, National Institutes of Health. Bethesda, Maryland. Surveillance, Epidemiology, and End Results (SEER) program: https://seer.cancer.gov/about/. 2020: Accessed, May 10, 2020.
- Geographical observation on cancer mortality by selected sites on the basis of standardised death rate.Gan. 1957; 48: 219-225
- Permutation tests for joinpoint regression with applications to cancer rates.Stat Med. 2000; 19: 335-351
- Global trends of bladder cancer incidence and mortality, and their associations with tobacco use and gross domestic product per capita.Eur Urol. 2020; 78: 893-906
- Worldwide burden of, risk factors for, and trends in pancreatic cancer.Gastroenterology. 2021; 160: 744-754
- Differences in incidence and mortality trends of colorectal cancer worldwide based on sex, age, and anatomic location.Clin Gastroenterol Hepatol. 2021; 19 (955–66.e61)
- Estimating average annual per cent change in trend analysis.Stat Med. 2009; 28: 3670-3682
- Model-based patterns in prostate cancer mortality worldwide.Br J Cancer. 2013; 108: 2354-2366
- Prostate cancer awareness and screening among men in a rural community in Kenya: a cross-sectional study.Afr J Urol. 2021; 27: 7
- Smoking as a risk factor for prostate cancer: a meta-analysis of 24 prospective cohort studies.Am J Public Health. 2010; 100: 693-701
- Alcohol and smoking and subsequent risk of prostate cancer in Japanese men: the Japan Public Health Center-based prospective study.Int J Cancer. 2014; 134: 971-978
- Cancer screening patterns among current, former, and never smokers in the United States, 2010-2015.JAMA Network Open. 2019; 2e193759
- Lifestyle and anthropometric risk factors for prostate cancer in a cohort of Iowa men.Ann Epidemiol. 2000; 10: 361-369
- Alcohol consumption, finasteride, and prostate cancer risk: results from the prostate cancer prevention trial.Cancer. 2009; 115: 3661-3669
- Relationship between acetaldehyde levels and cell survival in ethanol-metabolizing hepatoma cells.Hepatology. 2002; 35: 1196-1204
- Alcohol and cancer.Lancet Oncol. 2006; 7: 149-156
- Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies.J Natl Cancer Inst. 2008; 100: 170-183
- Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.J Cell Biochem. 2007; 102: 899-911
- Cancer surveillance series: interpreting trends in prostate cancer—part I: evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.J Natl Cancer Inst. 1999; 91: 1017-1024
- Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline.BMJ. 2018; 362: k3581
- Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.Ann Intern Med. 2008; 149: 185-191
- Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.Ann Intern Med. 2012; 157: 120-134
- Association of reductions in PSA screening across states with increased metastatic prostate cancer in the United States.J Clin Oncol. 2021; 39
- Is alcohol consumption a risk factor for prostate cancer? A systematic review and meta–analysis.BMC Cancer. 2016; 16: 845
- Difference in association of obesity with prostate cancer risk between US African American and Non-Hispanic White men in the selenium and vitamin e cancer prevention trial (SELECT).JAMA Oncology. 2015; 1: 342-349
- Metabolic syndrome and risk of cancer.Diabetes Care. 2012; 35: 2402
- Global, regional and time-trend prevalence of central obesity: a systematic review and meta-analysis of 13.2 million subjects.Eur J Epidemiol. 2020; 35: 673-683
- Worldwide incidence and prevalence of metabolic syndrome: a systematic review and meta-analysis of 14.6 million individuals.Gastroenterology. 2020; 158: S-1003